医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Inhibition of HIF-prolyl hydroxylase promotes renal tubule regeneration via the reprogramming of renal proximal tubular cells

摘要The ability of the mammalian kidney to repair or regenerate after acute kidney injury(AKI)is very limited.The maladaptive repair of AKI promotes progression to chronic kidney disease(CKD).Therefore,new strategies to promote the repair/regeneration of injured renal tubules after AKI are urgently needed.Hypoxia has been shown to induce heart regeneration in adult mice.However,it is unknown whether hypoxia can induce kidney regeneration after AKI.In this study,we used a prolyl hydroxylase domain inhibitor(PHDI),MK-8617,to mimic hypoxic conditions and found that MK-8617 significantly ameliorated ischemia reperfusion injury(IRI)-induced AKI.We also showed that MK-8617 dramatically facilitated renal tubule regeneration by promoting the proliferation of renal proximal tubular cells(RPTCs)after IRI-induced AKI.We then performed bulk mRNA sequencing and discovered that multiple nephrogenesis-related genes were significantly upregulated with MK-8617 pretreatment.We also showed that MK-8617 may alleviate proximal tubule injury by stabilizing the HIF-1α protein specifically in renal proximal tubular cells.Furthermore,we demonstrated that MK-8617 promotes the reprogramming of renal proximal tubular cells to Sox9+renal progenitor cells and the regeneration of renal proximal tubules.In summary,we report that the inhibition of prolyl hydroxylase improves renal proximal tubule regeneration after IRI-induced AKI by promoting the reprogramming of renal proximal tubular cells to Sox9+renal progenitor cells.

更多
广告
作者 Jing Li [1] Li-ting Chen [2] You-liang Wang [2] Mei-xia Kang [2] Shi-ting Liang [2] Xi-zhen Hong [2] Fan Fan Hou [2] Fu-jian Zhang [2] 学术成果认领
作者单位 Division of Nephrology,Nanfang Hospital,Southern Medical University;National Clinical Research Center for Kidney Disease;State Key Laboratory of Organ Failure Research;Guangdong Provincial Institute of Nephrology;Guangdong Provincial Key Laboratory of Renal Failure Research,Guangzhou 510515,China;Department of Critical Care Medicine,The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital,Zhengzhou 450008,China [1] Division of Nephrology,Nanfang Hospital,Southern Medical University;National Clinical Research Center for Kidney Disease;State Key Laboratory of Organ Failure Research;Guangdong Provincial Institute of Nephrology;Guangdong Provincial Key Laboratory of Renal Failure Research,Guangzhou 510515,China [2]
DOI 10.1038/s41401-024-01445-y
发布时间 2025-04-25(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
中国药理学报(英文版)

中国药理学报(英文版)

2025年46卷4期

1002-1015页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷